BR112016029236A2 - métodos para tratar prurido. - Google Patents

métodos para tratar prurido.

Info

Publication number
BR112016029236A2
BR112016029236A2 BR112016029236A BR112016029236A BR112016029236A2 BR 112016029236 A2 BR112016029236 A2 BR 112016029236A2 BR 112016029236 A BR112016029236 A BR 112016029236A BR 112016029236 A BR112016029236 A BR 112016029236A BR 112016029236 A2 BR112016029236 A2 BR 112016029236A2
Authority
BR
Brazil
Prior art keywords
methods
treating itching
itching
treating
Prior art date
Application number
BR112016029236A
Other languages
English (en)
Portuguese (pt)
Inventor
Sciascia Thomas
Original Assignee
Trevi Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trevi Therapeutics Inc filed Critical Trevi Therapeutics Inc
Publication of BR112016029236A2 publication Critical patent/BR112016029236A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR112016029236A 2014-06-13 2015-06-12 métodos para tratar prurido. BR112016029236A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462011936P 2014-06-13 2014-06-13
PCT/US2015/035650 WO2015192071A1 (en) 2014-06-13 2015-06-12 Methods for treating pruritus

Publications (1)

Publication Number Publication Date
BR112016029236A2 true BR112016029236A2 (pt) 2017-11-07

Family

ID=54834447

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016029236A BR112016029236A2 (pt) 2014-06-13 2015-06-12 métodos para tratar prurido.

Country Status (12)

Country Link
US (2) US20150359789A1 (https=)
EP (1) EP3154546A4 (https=)
JP (1) JP2017517553A (https=)
KR (1) KR20170016983A (https=)
CN (1) CN106535897A (https=)
AU (1) AU2015274327A1 (https=)
BR (1) BR112016029236A2 (https=)
CA (1) CA2951420A1 (https=)
IL (1) IL249475A0 (https=)
MX (1) MX2016016404A (https=)
RU (1) RU2017101102A (https=)
WO (1) WO2015192071A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
WO2017120468A1 (en) * 2016-01-06 2017-07-13 Trevi Therapeutics, Inc. Therapeutic use of nalbuphine without aquaretic effects
CN109310656A (zh) * 2016-03-21 2019-02-05 特雷维治疗股份有限公司 尿毒症性瘙痒症的治疗
MX2019004804A (es) * 2016-10-25 2019-08-22 Trevi Therapeutics Inc Tratamiento para el prurigo nodula.
RU2020130919A (ru) * 2018-03-29 2022-04-29 Лумоса Терапьютикс Ко., Лтд. Композиции и способы для лечения зуда
AU2019301134A1 (en) * 2018-07-11 2021-01-21 Trevi Therapeutics, Inc. Treatment of the pruritic symptoms of liver disease
JP2021531299A (ja) 2018-07-23 2021-11-18 トレビ セラピューティクス インコーポレイテッド 慢性咳嗽、息切れ、及び呼吸困難の治療
KR20220127849A (ko) 2020-01-10 2022-09-20 트레비 테라퓨틱스, 인코포레이티드 날부핀의 투여 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE053838T2 (hu) * 2005-08-24 2021-07-28 Endo Pharmaceuticals Inc Nyújtott felszabadulású nabulfin-készítmények
US8394812B2 (en) * 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
ES2396600T3 (es) * 2007-04-23 2013-02-22 Symrise Ag Ésteres de polietilenglicol y preparaciones cosméticas y/o dermatológicas
US8987289B2 (en) * 2012-12-14 2015-03-24 Trevi Therapeutics, Inc. Methods for treating pruritus
US8637538B1 (en) * 2012-12-14 2014-01-28 Trevi Therapeutics, Inc. Methods for treatment of pruritis
ES2984559T3 (es) * 2012-12-14 2024-10-29 Trevi Therapeutics Inc Métodos de tratamiento del prurito
US20140179727A1 (en) * 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus

Also Published As

Publication number Publication date
EP3154546A1 (en) 2017-04-19
AU2015274327A1 (en) 2017-01-05
RU2017101102A (ru) 2018-07-16
RU2017101102A3 (https=) 2019-01-28
JP2017517553A (ja) 2017-06-29
CN106535897A (zh) 2017-03-22
MX2016016404A (es) 2017-11-30
US20150359789A1 (en) 2015-12-17
CA2951420A1 (en) 2015-12-17
WO2015192071A1 (en) 2015-12-17
KR20170016983A (ko) 2017-02-14
IL249475A0 (en) 2017-02-28
EP3154546A4 (en) 2018-01-10
US20190099416A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
IL285435B (en) Systems and methods for treating pulmonary edema
IL257252A (en) Methods of treating fgf21-associated disorders
IL249981A0 (en) Method
DK3560954T3 (da) Modificeret j-kæde
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
BR112016029864A2 (pt) métodos e dispositivos para tratamento de desordens oculares posteriores.
CL2014003041S1 (es) Carcasa para aoutoinyector.
EP3227659C0 (en) THAWING PROCESSES
MA55696A (fr) Combinaisons
BR112016029236A2 (pt) métodos para tratar prurido.
BR112017002318A2 (pt) combinações de fármacos para tratar mieloma múltiplo.
BR112016027652A2 (pt) Método para produzir tiametoxam
FR3023988B3 (fr) .
PL3092003T3 (pl) Nowe przeciwciało przeciw netrynie-1
IL254783A0 (en) Anthelmintic combinations and methods of use thereof
ES1145159Y (es) Aparato para eliminar piojos.
IL252086A0 (en) Novel methods
CL2014003030S1 (es) Equipo para bebidas.
FI20145633A7 (fi) Menetelmä biolietteen käsittelemiseksi
PT3131549T (pt) Método para tratar distúrbios do movimento com befiradol
CL2016002609A1 (es) Biocida para aguas residuales
FI20145146A7 (fi) Laitteisto ketjukäyttöön
DK3237407T3 (da) 3,5-diaminopyrazolkinasehæmmere
FI20146005A7 (fi) Menetelmä massan valmistamiseksi.
ES1135628Y (es) Monoboya para vertido controlado

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements